Qian, J.,
Zhuang, F.,
Chen, Y.,
Fan, X.,
Wang, J.,
Wang, Z.,
Wang, Y.,
Xu, M.,
Samorodov, A.V.,
Pavlov, V.N.,
Liang, G. (2022) in DCM and to test the therapeutic effects of MD2
inhibitor C30 on DCM. Streptozotocin (STZ) was used
Yagudin, T,
Zhao, Y,
Gao, HY,
Zhang, Y,
Yang, Y,
Zhang, XF,
Ma, WB,
Daba, TM,
Ishmetov, V,
Kang, K,
Yang, BF,
Pan, ZW (2021) infarction in order to facilitate the development of novel therapy.
Inhibitor of apoptosis
LIU, Z.,
WANG, X.,
YANG, G.,
ZHONG, C.,
ZHANG, R.,
YE, J.,
ZHONG, Y.,
HU, J.,
OZAL, B.,
ZHAO, S. (2020) kinase and Ras signaling pathways. CMap analysis revealed four small-molecule compounds that could
Zhao, X.,
Sun, J.,
Su, W.,
Shan, H.,
Zhang, B.,
Wang, Y.,
Shabanova, A.,
Shan, H.,
Liang, H. (2018) fibroblasts. Additionally, we determined that luzindole, a melatonin receptor
inhibitor, reduced the anti